SM2 Advisors
  • SERVICES
  • LEADERSHIP
  • CASE STUDIES
  • GET IN TOUCH
September 28, 2018  |  By Endo International plc  |  In In The Press, News & Updates, Product Recalls

Endo Pharmaceuticals Issues Voluntary Nationwide Recall for Two Lots of Robaxin® 750mg Tablets 100 Count Bottle Packs Due to Incorrect Daily Dosing Information on Label

Endo_International_plc_Robaxin_LabelDUBLIN, Sept. 28, 2018 /PRNewswire/ — Endo International plc (NASDAQ: ENDP) today announced that one of its operating companies, Endo Pharmaceuticals Inc., is voluntarily recalling two lots of Robaxin® (methocarbamol tablets, USP) 750mg Tablets 100 Count Bottle pack to the consumer…

Read More 0
March 9, 2018  |  By Berlinger Special AG  |  In In The Press, News & Updates, Product Recalls

Berlinger Resolves Medium-term Withdrawal From the Doping Control Kit Business but Pledges to Help Prevent Interim Shortages

GANTERSCHWIL, Switzerland, March 9, 2018 /PRNewswire/ —
The Board of Directors of Berlinger Special AG has resolved that the company will cease production of its doping control kits in the medium term. To avoid jeopardizing current anti-doping act…

Read More 0
March 9, 2018  |  By Berlinger Special AG  |  In In The Press, News & Updates, Product Recalls

Berlinger Resolves Medium-term Withdrawal From the Doping Control Kit Business but Pledges to Help Prevent Interim Shortages

GANTERSCHWIL, Switzerland, March 9, 2018 /PRNewswire/ —
The Board of Directors of Berlinger Special AG has resolved that the company will cease production of its doping control kits in the medium term. To avoid jeopardizing current anti-doping act…

Read More 0

Categories

  • Aboriginal, First Nations & Native American (4)
  • ACC (246)
  • Accounting News & Issues (1,073)
  • Acquisitions, Mergers and Takeovers (2,651)
  • Advocacy Group Opinion (59)
  • African American (15)
  • Animal Welfare (49)
  • Animals & Pets (137)
  • ANW (55)
  • ASI (28)
  • Asian American (101)
  • ATY (414)
  • AVO (170)
  • Awards (1,313)
  • AWD (1,216)
  • Bankruptcy (6)
  • BCY (8)
  • BFA (227)
  • BLK (59)
  • Bond & Stock Ratings (6)
  • Broadcast Feed Annoucement (136)
  • Canadian Federal Government (2)
  • CCA (498)
  • CFG (2)
  • CHI (287)
  • Children (196)
  • Clinical Trials & Medical Discoveries (610)
  • completed (1)
  • CON (656)
  • Conference Call Announcements (412)
  • Conferences (13)
  • Conservation, Recycling (99)
  • Contracts (1,762)
  • Corporate Expansion (1,113)
  • Corporate Social Responsibility (235)
  • CPN (6)
  • CSR (353)
  • CXP (674)
  • DIS (31)
  • Disabled (1)
  • DIV (256)
  • divestiture (1)
  • Dividends (57)
  • Domestic Policy (25)
  • DSC (3)
  • Earnings (443)
  • Earnings Forecasts & Projections (91)
  • ECO (197)
  • Economic News, Trends, Analysis (237)
  • EGV (10)
  • ENI (74)
  • ENP (21)
  • Environmental Issues (154)
  • Environmental Policy (46)
  • ERN (330)
  • ERP (104)
  • European Government (61)
  • Events (6)
  • EXE (25)
  • FDA (46)
  • FDA Approval (62)
  • FEA (12)
  • Features (131)
  • Federal & State Legislation (3)
  • Federal Executive Branch & Agency (5)
  • Financing Agreements (235)
  • FNC (146)
  • FOR (134)
  • Foreign Policy & International Affairs (170)
  • foreign_deals (1)
  • fsa.ACQ (2)
  • fsa.ACS (4)
  • fsa.AGR (1)
  • fsa.BLR (2)
  • fsa.BOA (6)
  • fsa.CIR (2)
  • fsa.CON (1)
  • fsa.CRO (1)
  • fsa.DIV (4)
  • fsa.DOC (2)
  • fsa.DRL (1)
  • fsa.DSH (17)
  • fsa.FR (5)
  • fsa.HOL (15)
  • fsa.IOE (22)
  • fsa.IR (8)
  • fsa.MSC (41)
  • fsa.NAV (572)
  • fsa.NOA (1)
  • fsa.NOG (2)
  • fsa.PFU (6)
  • fsa.POS (49)
  • fsa.PSP (1)
  • fsa.QRT (2)
  • fsa.RAG (6)
  • fsa.RDN (5)
  • fsa.RET (41)
  • fsa.STR (20)
  • fsa.TEN (1)
  • fsa.TSM (43)
  • fsa.TVR (11)
  • fsa.UPD (2)
  • FVT (1,497)
  • Handicapped, Disabled (12)
  • Hispanic (21)
  • HSP (268)
  • In The Press (59,288)
  • INO (75)
  • Investments Opinions (699)
  • Joint Ventures (594)
  • JVN (177)
  • Labor & Union (4)
  • LAW (169)
  • LBR (49)
  • LEG (60)
  • Legal Issues (229)
  • Lesbian, Gay & Bisexual (13)
  • LGB (23)
  • LIC (481)
  • Licensing (580)
  • Management_Change (1)
  • MAT (270)
  • mergersNews (12,240)
  • Miscellaneous (2)
  • NAT (34)
  • Natural Disasters (20)
  • New Products & Services (4,890)
  • News & Updates (59,663)
  • Not For Profit (373)
  • NPT (659)
  • NTA (14)
  • OBI (31)
  • Obituaries (6)
  • OFR (133)
  • Oil and Gas Discoveries (19)
  • Patent Law (58)
  • PDT (2,805)
  • PER (1,009)
  • Personnel Announcements (1,079)
  • PET (104)
  • PLW (46)
  • POL (45)
  • Political Campaigns (5)
  • private (1)
  • Private Placement (2)
  • Product Recalls (3)
  • PSF (125)
  • Public Safety (104)
  • PVP (8)
  • RCL (22)
  • RCN (43)
  • RCY (57)
  • Real Estate Transactions (43)
  • REL (71)
  • Religion (45)
  • Restructuring & Recapitalization (30)
  • RLE (56)
  • RTG (2)
  • Sales Reports (90)
  • SBS (146)
  • SCZ (62)
  • Senior Citizens (24)
  • SHA (18)
  • Shareholder Activism (28)
  • Shareholders' Rights Plan (16)
  • SLS (70)
  • Small Business Services (78)
  • smallcap (1)
  • Socially Responsible Investing (12)
  • SRI (12)
  • Stock Offering (112)
  • Stock Split (4)
  • Stock_Offerings_( (1)
  • STP (13)
  • STS (3)
  • Surveys, Polls and Research (9,274)
  • SVY (3,495)
  • TDS (1,295)
  • TNM (594)
  • Trade Policy (32)
  • Trade Show News (2,095)
  • TRD (11)
  • TRI (284)
  • U.S. State Policy (5)
  • Uncategorized (21)
  • uspublic (1)
  • VEN (92)
  • Venture Capital (217)
  • VET (54)
  • Veterans (1)
  • volume_value (1)
  • WOM (198)
  • Women (197)
SM2 Advisors
  • WHY HIRE AN ADVISOR?
  • FAQ
  • INDUSTRY NEWS
  • CONTACT
Copyright ©2016 SM2 Advisors. All Rights Reserved.